STOCK TITAN

BeOne Medicines’ Chan Lee proposes $1.17M ADS sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

BeOne Medicines Ltd. (ONC) officer Chan Lee filed notice of a proposed sale of 2,895 ADS, with an aggregate market value of $1,168,422.00; the approximate sale date is November 19, 2026. The notice states Chan Lee acquired 2,895 ADS on November 19, 2026 through an exercise of stock options. It also identifies two prior 10b5-1 sales: 1,115 ADS on November 5, 2026, for gross proceeds of $446,909.95, and 1,115 ADS on September 30, 2026, for $418,125.00.

Proposed sale 2,895 ADS Approximate sale date November 19, 2026
Aggregate market value $1,168,422.00 Proposed sale of 2,895 ADS
ADS outstanding 58,926,111 ADS Number outstanding in the securities information
Prior sale 1,115 ADS November 5, 2026; identified as a 10b5-1 sale
Gross proceeds $446,909.95 Sale on November 5, 2026
Prior sale 1,115 ADS September 30, 2026; identified as a 10b5-1 sale
Gross proceeds $418,125.00 Sale on September 30, 2026
ADS technical
"Title of the Class of Securities To Be Sold: ADS"
Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"Nature of Acquisition Transaction: Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADS is BeOne Medicines officer Chan Lee proposing to sell?

Chan Lee's notice lists 2,895 ADS for sale, with an approximate sale date of November 19, 2026 and an aggregate market value of $1,168,422.00.

What prior 10b5-1 sales did Chan Lee report for BeOne Medicines (ONC)?

The notice lists two prior 10b5-1 sales of 1,115 ADS each: 1,115 ADS on November 5, 2026, for gross proceeds of $446,909.95, and 1,115 ADS on September 30, 2026, for $418,125.00.

What 10b5-1 plan date is listed for Chan Lee's BeOne Medicines sale?

The notice lists May 29, 2026 as the date of plan adoption or giving of instruction, if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading